Search results
Results from the WOW.Com Content Network
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol ...
Panama City Beach is a resort town in the Florida Panhandle, and principal city of the Panama City Metropolitan Area. It is a popular vacation destination, especially among people in the Southern United States, and is located in the "Emerald Coast" area. Panama City Beach had a population of 18,094 at the 2020 census, up from 12,018 in 2010. [4]
US 98 runs east–west through the city itself, leading southeast 24 miles (39 km) to Mexico Beach and west 10 miles (16 km) to Panama City Beach. The two main north–south thoroughfares in the city are Martin Luther King Boulevard, otherwise known as SR 77 and US 231. SR 77 leads north six miles (9.7 km) to the Panama City suburb of Lynn Haven.
This is a list of countries by stem cell research trials for the purpose of commercializing treatments as of June 2020, ... Panama: 79 13 United Kingdom: 72 ...
Peripheral blood stem cell transplantation (PBSCT), also called "Peripheral stem cell support", [1] is a method of replacing blood-forming stem cells.Stem cells can be destroyed through cancer treatments such as chemotherapy or radiation, as well as any blood-related diseases, such as leukemia, lymphoma, neuroblastoma and multiple myeloma. [2]
StemCell Technologies Canada Inc. (formerly known as StemCell Technologies Inc.) is a Canadian biotechnology company that develops and manufactures cell culture media and cell separation technologies for use in stem cell, immunology, and cancer research.
Stem cell research policy varies significantly throughout the world. There are overlapping jurisdictions of international organizations, nations, and states or provinces. Some government policies determine what is allowed versus prohibited, whereas others outline what research can be publicly financ
Astellas Institute for Regenerative Medicine is a subsidiary of Astellas Pharma located in Marlborough, Massachusetts, US, developing stem cell therapies with a focus on diseases that cause blindness. It was formed in 1994 as a company named Advanced Cell Technology, Incorporated (ACT), which was renamed to Ocata Therapeutics in November 2014. [3]